Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals

Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.

We haven't written up this one. CNBC World has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at cnbc.com →

More in Finance & Markets

IMF chief says world economy faces multiple risks despite resilience

NEW YORK: The world economy faces risks from stubborn inflation, higher debt service costs and investment in artificial intelligence (AI), although it has proven more resilient than many feared, according to International Monetary Fund (IMF) Managing Director Kristalina Georgieva, reported Xinhua.

BDX Markets launches blockchain trading platform across Asian financial markets

Financial technology company BDX Markets deployed a hybrid trading infrastructure platform incorporating distributed ledger technology across Asia to strengthen transaction verification for market…

  • BDX Markets launches blockchain trading platform in Asia
  • Addresses transparency concerns in CFD trading industry
  • Hybrid infrastructure model preserves MT5 platform

US, China Begin Trade Talks in New York

"Bloomberg: The Asia Trade" brings you everything you need to know to get ahead as the trading day begins in Asia. Bloomberg TV is live from Sydney with Haidi Stroud-Watts and Paul Allen, getting…

More from Monday 21 September →